According to the Madison Record, a $4.35 million Madison County Xarelto lawsuit has been transferred to the multidistrict litigation court, where it joins roughly 250 similar Xarelto lawsuits. The lawsuit stems from a 90-count complaint filed in January against the various companies responsible for Xarelto, including Bayer and Johnson & Johnson’s Janssen Pharmaceuticals. The plaintiff has accused the manufacturers of Xarelto of overstating the efficacy of their drug ...
$4 Million Xarelto Lawsuit Added to Xarelto MDL
Posted July 14, 2015 in Product News and Recalls | xarelto
FDA Fast Tracks Boehringer’s Pradaxa Antidote
Posted May 14, 2015 in Product News and Recalls | xarelto
The U.S. Food and Drug Administration (FDA) has given Boehringer Ingelheim’s antidote to its problematic anticoagulant drug Pradaxa a fast-track review, FiercePhrama reports. According to the company, this will make Pradaxa the first “next generation” anticoagulant to receive an FDA-approved antidote.
Last year, the German drug manufacturer Boehringer Ingelheim agreed to pay $650 million to settle roughly 4,000 Pradaxa lawsuits in state and federal courts. Plaintiffs ...
continue reading...Xarelto Lawsuit Filed by California Man
Posted May 7, 2015 in Product News and Recalls | xarelto
A California man has filed a Xarelto lawsuit against multiple pharmaceutical companies for damages allegedly caused by the blood-thinning medication. The plaintiff claims that the defendants, including Johnson & Johnson’s Janssen Pharmaceuticals, overstated the efficacy and safety of Xarelto. The complaint alleges that no antidote exists for Xarelto in the event of hemorrhagic complications.
Like plaintiffs in other Xarelto lawsuits, the California man alleges that the defendants failed ...
continue reading...Where Are Liptor Cases Filed?
Posted April 28, 2014 in Lipitor | Product News and Recalls
An estimated 29 million Americans take Lipitor, a prescription medication that works to lower cholesterol, as well as the risk of stroke, chest pains, heart attack, and other blood vessel and heart problems. While meant to help patients stay healthy, many people blame the drug for the development of some dangerous health conditions. In fact, many Americans who took Lipitor have filed lawsuits alleging that Lipitor caused Type 2 diabetes in women.
If you are a woman and have developed ...
continue reading...Ramon Lopez Appointed to Plaintiffs’ Executive Committee in Multidistrict Lipitor Litigation
Posted April 10, 2014 in Product News and Recalls
Lopez McHugh LLP is pleased to announce that principal partner Ramon R. Lopez has been appointed to the Plaintiffs’ Executive Committee (PEC) in the multidistrict litigation (MDL) regarding Lipitor, titled In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Products Liability Litigation (MDL – 2502). 270 claims were filed against Pfizer, maker of Lipitor, and have been consolidated into this MDL, which was centralized in the United States District ...
Multidistrict Litigation Established for Stryker Hip Implant Cases
Posted October 11, 2013 in Drug and Medical Device Lawsuits | Product News and Recalls
As a result of the increasing number of Stryker hip implant cases filed around the country, the United States Judicial Panel on Multidistrict Litigation has ordered the creation of a multidistrict litigation (MDL) so that a single judge can efficiently handle all of these cases.
MDLs are centralized locations for all federal cases involving a particular form of litigation, ...
continue reading...
